The entire coding region of the gene can be amplified with only a few PCR primers using genomic DNA. The consequences ofmutations are easily assessed by measuring the CHE activity with routine laboratory tests.
Serum cholinesterase
(CHE, butyrylcholinesterase) is a cholinester hydrolysing enzyme that is synthesised in the liver. Its (fig 2) . This mutation is known to cause dibucaine resistant variant8 and the loss Sau3A restriction site (GATC-+GGTC). fig 1) , homozygous for the insertion.
Sequencing of fragment seq5/13, which covers 252 bp at the 3' end of fragment 15/13, with sequencing primer seq5 showed a frameshift mutation (GGT--GGAG) at position 351, resulting in the appearance of a stop codon at nucleotide 384. Both parents were found to be heterozygous for this mutation. Two sisters and one brother with very low CHE activity were homozygous for the insertion (fig 3) . This mutation is known to cause a silent variant. 3 A guanine to adenine polymorphism at nucleotide position 1615 has been found to cause the K variant, which is characterised by a reduction of about one third in cholinesterase activity.4 ' 12 This polymorphism appears to be in close linkage to the mutation at position 209, which causes the dibucaine resistant variant. SSCP analysis of fragment 55/53, which covers the K variant coding region, did not show any difference between family members and the control. We therefore decided to sequence this fragment with primers 55/5 and 53 using primer 55/5 as sequencing primer. Sequencing results showed guanine at position 1615 in all family members (data not shown).
Discussion
We have applied PCR-SSCP analysis to characterise the molecular defect in a family with acholinesterasaemia. This technique proved to be a rapid and powerful approach to screen the CHE gene for mutations. The mutations detected, the G to A transition at nucleotide 209 as well as the AG insertion at nucleotide 351, are within fragment 15-13. They both caused characteristic SSCP resulting in four different band patterns for the entire family ( fig  1) . The SSCP technique is most sensitive when examining DNA fragments of 100 to 300 bp, showing mobility shifts of at least one strand in 70 to 99% of mutations.8 The sensitivity of the method decreases with the size of the PCR product and is less than 50% when the fragment is >400 bp. To overcome this size limitation we digested fragment 25-33 (1088 bp) with HphI before SSCP analysis.
A number of CHE variants have been described and their molecular bases have been characterised.2A Our interest in this family arose from two observations. Cholinesterase activities in the parents did not seem to fit well with current knowledge of CHE variants. In addition, family members were Jordanian Arabs and little is known about the molecular basis for a silent allele as three children were expected to be homozygous for a silent allele (fig 1) . Despite the suspected heterozygosity the mother had a normal CHE activity. The dibucaine inhibition number of the father suggested that he was either homozygous for the dibucaine resistant variant or heterozygous for dibucaine resistance and a silent variant. In either case two of the sons had to be heterozygous for the dibucaine resistant variant, despite their high CHE activity, because they were not carriers of a silent allele.
The mother and the father were found to be heterozygous and three children homozygous for a GGT to GGAG frameshift mutation. This mutation leads to a stop codon at nucleotide illl P. mia group.bmj.com on June 22, 2017 -Published by http://jmg.bmj.com/ Downloaded from 384, generating a truncated protein that lacks the active catalytic site.3 No data are available on the frequency of the silent allele, but it is probably very rare.2 Its presence in the mother and the father in this family is most likely because they are cousins.
Furthermore the father was heterozygous for a point mutation at nucleotide 209, known to cause the dibucaine resistant variant.3 The two sons with normal CHE activity were also heterozygous for this mutation. The dibucaine resistant variant shows a reduced affinity for binding cholinester substrates such as succinylcholine and a reduced degree of inhibition by dibucaine."3 This variant is clinically important because the muscle relaxant succinylcholine is frequently used in anaesthesia. In whites the atypical allele has a gene frequency of 0-017'4 and about 3 in 10 000 are homozygous for the atypical variant.
In a North American population the dibucaine resistant variant has been found to be closely linked to a polymorphism at position 1615 resulting from a G to A transition (GCA-+ACA). 4 The frequencies of the polymorphic alleles are 0-875 (GCA) and 0-125 (ACA). ACA codes for the K variant, a quantitative variant with an activity reduced by 33%.412 It is believed that the linkage to the K variant accounts for the fact that atypical serum contains one third less esterase protein than is present in usual serum.4' SSCP analysis of fragment 55-53, which contains this polymorphism, did not show any differences between the control and family members. We therefore proceeded to sequence this fragment with primer 55/5. We found GCA coding for alanine in all four alleles of the parents. This finding probably explains the normal CHE activity in the two sons despite their being heterozygous for the dibucaine resistant variant. In addition, it supports the hypothesis ofBartels et al4 that the K variant is responsible for the observed reduction in CHE activity in atypical serum.
As CHE variants and deficiencies have no influence on health apart from prolonged muscle relaxation after succinylcholine they presumably could evolve without selection pressure to eliminate certain CHE variants from the population. Most of the work on the molecular basis of CHE variants has been done in North American patients."4 Unfortunately, the authors do not state the ethnic origin of these patients. We could identify the same mutations in this family of Jordanian Arabs, which leads us to suppose that there is considerable molecular homogeneity between ethnic groups. With regard to the dibucaine resistant variant our family did not show the linkage to the K variant that has been reported from North America.4
